VF
HEPA

Virtu Financial’s Hepion Pharmaceuticals HEPA Stock Holding History

Virtu Financial’s Portfolio HEPA Stock Details HEPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-250
Closed -$41K – 1683
2023
Q4 		$41K Buy
+250
New +$47.3K ﹤0.01% 1208
2023
Q2 		– Sell
-54
Closed -$42K – 1713
2023
Q1 		$42K Buy
54
+33
+157% +$24.4K ﹤0.01% 1126
2022
Q4 		$6K Sell
21
-47
-69% -$19.9K ﹤0.01% 1432
2022
Q3 		$34K Buy
68
+45
+196% +$27.5K ﹤0.01% 1287
2022
Q2 		$13K Buy
+23
New +$19.2K ﹤0.01% 1399
2022
Q1 		– Sell
-50
Closed -$57K – 1709
2021
Q4 		$57K Buy
+50
New +$68.5K 0.01% 1309
2021
Q3 		– Sell
-114
Closed -$225K – 1686
2021
Q2 		$225K Sell
114
-65
-36% -$119K 0.02% 914
2021
Q1 		$329K Buy
+179
New +$392K 0.02% 763
2019
Q4 		$79K Sell
15
-3
-17% -$11.6K 0.01% 1127
2019
Q3 		$44K Sell
18
-16
-47% -$46.4K ﹤0.01% 1217
2019
Q2 		$140K Buy
+34
New +$347K 0.01% 1077
2019
Q1 		– Sell
-1
Closed -$19.4K – 1363
2018
Q4 		$16K Buy
+1
New +$34.3K ﹤0.01% 1397
2018
Q3 		– Hold
0
– – – 1458
2018
Q2 		– Hold
0
– -$2K – 2196
2018
Q1 		– Hold
0
– – – 1874
2017
Q4 		– Hold
0
– – – 2025
2017
Q3 		– Hold
0
– – – 2366

Other funds holding HEPA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Virtu Financial's HEPA Position: Q1 2024 in Review

Virtu Financial sold out of Hepion Pharmaceuticals (HEPA) in Q1 2024, closing a stake of 250 shares — an estimated $41K sold.

Virtu Financial first reported a position in HEPA in Q4 2018 and held it in 12 quarters. The position peaked at $329K in Q1 2021. 16 funds tracked by Wall St. Rank hold HEPA as of Q1 2024.

  • Virtu Financial reported no remaining Hepion Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 250 Hepion Pharmaceuticals shares in Q1 2024, an estimated $41K.
  • Virtu Financial first reported a position in Hepion Pharmaceuticals in Q4 2018 and held it in 12 quarters.
  • Virtu Financial's Hepion Pharmaceuticals position peaked at $329K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.